MedPath

Isosorbide Mononitrate

Isosorbide Mononitrate Extended-Release Tablets, USP

Approved
Approval ID

96420729-2bc7-4d03-9c51-f786ea678998

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 26, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Isosorbide Mononitrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-2192
Application NumberANDA210918
Product Classification
M
Marketing Category
C73584
G
Generic Name
Isosorbide Mononitrate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 22, 2021
FDA Product Classification

INGREDIENTS (7)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE 2208 (100000 MPA.S)Inactive
Code: VM7F0B23ZI
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ISOSORBIDE MONONITRATEActive
Quantity: 60 mg in 1 1
Code: LX1OH63030
Classification: ACTIB
HYDROXYPROPYL CELLULOSE (1200000 WAMW)Inactive
Code: U3JF91U133
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Isosorbide Mononitrate - FDA Drug Approval Details